All Stories

  1. Dermoscopy of Subungual Squamous Cell Carcinoma: A Systematic Review
  2. Bullous Rheumatoid Neutrophilic Dermatosis—A Systematic Review of 28 Cases
  3. Lupus mastitis heralding macrophage activation syndrome: Case report and systematic review of the literature
  4. A Paradigm Shift in the Pathophysiology and Treatment of Chronic Kidney Disease–Associated Pruritus
  5. A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study
  6. Are we missing true therapeutic outcomes in hidradenitis suppurativa by using HiSCR? A lesson learned from the SHINE trial
  7. Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals
  8. Benefits of a Compensating Dermocosmetic Routine as an Adjunct to Treatments in Patients With Mild to Very Severe Acne: Results From an Observational Multicenter Study
  9. Sexual Health in Patients with Atopic Dermatitis: A Cross-Sectional Study
  10. Prurigo nodularis is a Th‐2‐mediated immune disease
  11. A multidisciplinary Delphi consensus on the modern definition of pruritus: Sensation and disease
  12. Breaking the itch cycle: long-term effects of nemolizumab in prurigo nodularis
  13. Inflammation-Related Markers in Pediatric Psoriasis: Resistin as a Potential Marker of Psoriasis Severity
  14. Clinical Utility of Various Formulations of Calcipotriene and Betamethasone Dipropionate for the Treatment of Plaque Psoriasis in Patients Aged 12 Years or Older
  15. Porokeratoses—A Rare Group of Dermatoses
  16. Applying the Atomic Force Microscopy Technique in Medical Sciences—A Narrative Review
  17. Evaluation of hair surface structure and morphology of patients with lichen planopilaris (LPP) by atomic force microscopy (AFM)
  18. Inherited ichthyoses patients: Individualized care and support urgently needed
  19. Pruritus in Lichen Planopilaris and Frontal Fibrosing Alopecia—Clinical Characteristics and Dermoscopic Correlations
  20. Effectiveness and Safety of Etanercept in Paediatric Patients with Plaque-Type Psoriasis: Real-World Evidence
  21. Itch improvement has a major and comparable effect on the Dermatology Life Quality Index in psoriasis and atopic dermatitis patients
  22. An Update on Non-Invasive Skin Imaging Techniques in Actinic Keratosis—A Narrative Review
  23. Chronic nodular prurigo: Association between comorbidities, itch and quality of life
  24. Nemolizumab: a new key player in the treatment of prurigo nodularis
  25. Evaluation of Surface Structure and Morphological Phenomena of Caucasian Virgin Hair with Atomic Force Microscopy
  26. Classification of psychodermatological disorders: Proposal of a new international classification
  27. Occupational Exposure of Employees in a Multispecialty Hospital to Factors Causing Contact Dermatitis—A Questionnaire Study
  28. Reflectance Confocal Microscopy and Dermoscopy of Facial Pigmented and Non-Pigmented Actinic Keratosis Features before and after Photodynamic Therapy Treatment
  29. Photodynamic Therapy in Pigmented Basal Cell Carcinoma—A Review
  30. Skin-Related Sexual Life Questionnaire (SRSLQ): Creation and Validation of the Questionnaire
  31. Pathomechanism of Pruritus in Psoriasis and Atopic Dermatitis: Novel Approaches, Similarities and Differences
  32. Successful Treatment of Pityriasis Rubra Pilaris with Risankizumab in Children
  33. Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies
  34. Seeking new topical therapies in psoriasis
  35. Speed of clinical improvement in the real‐world setting from patient‐reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks
  36. Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
  37. Skin Microbiome in Prurigo Nodularis
  38. Chronic prurigo: Insufficient disease control in spite of high healthcare usage
  39. Risankizumab Therapy for Moderate-to-Severe Psoriasis—A Multi-Center, Long-Term, Real-Life Study from Poland
  40. A novel, fixed‐dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30thEADV Congress 2021
  41. Tolerance and efficacy of a spray containing Rhealba oat plantlets and Uncaria tomentosa extracts in reducing symptoms of herpes zoster
  42. The role of interleukins 6, 8, 17 and 23 in the pathogenesis of pyoderma gangrenosum
  43. Sexual Dysfunction in Women and Men with Psoriasis: A Cross-Sectional Questionnaire-Based Study
  44. The Impact of Pruritus on the Quality of Life and Sleep Disturbances in Patients Suffering from Different Clinical Variants of Psoriasis
  45. Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO)
  46. Dermoscopic Features of Acute, Subacute, Chronic and Intermittent Subtypes of Cutaneous Lupus Erythematosus in Caucasians
  47. Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances
  48. The Analysis of a Genome-Wide Association Study (GWAS) of Overweight and Obesity in Psoriasis
  49. Efficacy, quality of life, and treatment satisfaction: an indirect comparison of calcipotriol/betamethasone dipropionate cream versus foam for treatment of psoriasis
  50. Comparative effectiveness of adalimumab versus ustekinumab in the treatment of severe chronic plaque psoriasis: The results based on data from the program “treatment of moderate and severe forms of plaque psoriasis (B.47)” of the National Health Fund i...
  51. Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life
  52. COVID-19 and Postural Control—A Stabilographic Study Using Rambling-Trembling Decomposition Method
  53. Dermoscopy and Trichoscopy in Dermatomyositis—A Cross-Sectional Study
  54. Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
  55. The Case of a Patient with Limited Systemic Sclerosis and Interstitial Lung Disease Overlapping with Systemic Lupus Erythematosus
  56. Pruritus and prurigo: a significant advancement on diagnosis, classification, pathogenesis and treatment
  57. Dermoscopic Features of Lichen Amyloidosis in Caucasians—A Case Series and Literature Review
  58. Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate‐to‐severe psoriasis: a post hoc analysis from IXORA‐PEDS
  59. Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity
  60. Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature
  61. Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the Literature
  62. Characteristics of Pruritus in Various Clinical Variants of Psoriasis: Results of the Multinational, Multicenter, Cross-Sectional Study
  63. Pyoderma Gangrenosum with an Underlying Leukocyte Adhesion Deficiency Type 1 (LAD-1) and Pregnancy in the Shade of COVID-19 Epidemic: A Patient and Physician Experience
  64. Pack-year cigarette smoking affects the course of palmoplantar pustulosis
  65. Treatment of Mild-to-Moderate Plaque Psoriasis with a New 650-Microsecond 1064-nm Nd:YAG Laser: Clinical and Dermoscopic Assessment
  66. Molecular Aspects of Pruritus Pathogenesis in Psoriasis
  67. The Significance of Autoantibodies in Juvenile Dermatomyositis
  68. Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea—A Systematic Review of the Literature
  69. Comparison of the impact of childhood psoriasis on mothers’ and fathers’ quality of life – does gender of a caregiver play a role?
  70. Reliable assessment of atopic dermatitis severity: do we need more tools?
  71. Mepolizumab Therapy for Recalcitrant Eosinophilic Annular Erythema in an Adult: A Case Report and Review of Treatment Options
  72. A spray containing extracts of oat plantlets and Uncaria tomentosa relieves pain associated with chronic inflammatory skin diseases and dermatological procedures
  73. Chronic nodular prurigo: clinical profile and burden. A European cross‐sectional study
  74. Periorbitale erythematöse Plaques und Papeln bei einem HIV-positiven Patienten
  75. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
  76. Landscape of current and future therapies of Merkel cell carcinoma
  77. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis
  78. Quality of Life in Patients with Morphea: A Cross‐Sectional Study and a Review of the Current Literature
  79. Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part I. Prophylaxis, topical treatment ...
  80. Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part II. Systemic treatment and new the...
  81. Pathogenesis of psoriasis in the “omic” era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances
  82. Prevalence of Prurigo Nodularis in Poland
  83. Rheumatoid neutrophilic dermatitis
  84. Pathophysiology and management of sensitive skin: position paper from the special interest group on sensitive skin of the International Forum for the Study of Itch (IFSI)
  85. Delusions of Parasitosis: An Update
  86. Pruritus Associated with Commonly Prescribed Medications in a Tertiary Care Center
  87. Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review
  88. NK-1 Receptor Antagonists and Pruritus: Review of Current Literature
  89. Beyond PD-1 Immunotherapy in Malignant Melanoma
  90. Validation of ‘ItchApp©’ in Poland and in the USA: multicentre validation study of an electronical diary for the assessment of pruritus
  91. Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part II. Systemic treatment and new the...
  92. Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part I. Prophylaxis, topical treatment ...
  93. Clinical characteristics and epidemiology of chronic urticaria: a nationwide, multicentre study on 1091 patients
  94. Minimal Clinically Important Difference in Chronic Pruritus Appears to be Dependent on Baseline Itch Severity
  95. Risk of cardiovascular diseases in psoriasis – the current state of knowledge
  96. Symmetric acral annular erythema: a variant of erythema annulare centrifugum, necrolytic acral erythema or a distinct clinical entity?
  97. Vitiligo. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
  98. Evaluation of Antibiotic Treatment on the Duration of Hospitalization of Patients with Erysipelas and Bacterial Cellulitis
  99. Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies
  100. Position Statement: Linear prurigo is a subtype of chronic prurigo
  101. Cross-European validation of the ItchyQoL in pruritic dermatoses
  102. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial
  103. Trichotillomania and Trichophagia: Modern Diagnostic and Therapeutic Methods
  104. Prevalence of Pruritus in Cutaneous Lupus Erythematosus: Brief Report of a Multicenter, Multinational Cross-Sectional Study
  105. UCHL1/PGP 9.5 Dynamic in Neuro-Immune-Cutaneous Milieu: Focusing on Axonal Nerve Terminals and Epidermal Keratinocytes in Psoriatic Itch
  106. Paraneoplastic systemic sclerosis associated with colorectal carcinoma
  107. Analysis of sexual problems in men with psoriasis
  108. Psychosocial aspects of rosacea with a focus on anxiety and depression
  109. Pruritus: From the Bench to the Bedside
  110. Assessment of pruritus in patients with viral hepatitis B and C
  111. Chronic venous insufficiency – epidemiology, classification and clinical picture. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part I
  112. Chronic venous insufficiency – pathogenesis, diagnosis and pharmacological treatment. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part II
  113. Clinical presentation of erythema nodosum
  114. Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
  115. Disease severity and prophylactic measures in patients with cutaneous lupus erythematosus: results of a worldwide questionnaire-based study
  116. Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part I: Mild psoriasis
  117. Slowly Progressing Asymptomatic Disseminated Telangiectasias: A Quiz
  118. Biologics for Itch: IL-4/IL-13, IL-31, IL-17, and IL-23 Antagonists
  119. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo
  120. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment
  121. JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment
  122. Large-scale human skin lipidomics by quantitative, high-throughput shotgun mass spectrometry
  123. Interleukin-17 blockade in generalized pustular psoriasis - new hope for severely ill patients
  124. Trigger factors of cutaneous lupus erythematosus: a review of current literature
  125. 12-Item Pruritus Severity Scale: Development and Validation of New Itch Severity Questionnaire
  126. Prevalence and Relevance of Pruritus in Pregnancy
  127. Determinants of Psychosocial Health in Psoriatic Patients: A Multi­national Study
  128. Antihistamines in the treatment of pruritus in psoriasis
  129. Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA
  130. Clinical Aspects of Itch in Lichen Planus
  131. Definition of Sensitive Skin: An Expert Position Paper from the Special Interest Group on Sensitive Skin of the International Forum for the Study of Itch
  132. Expression of SOX18 in Mycosis Fungoides
  133. Opioid Receptors in Psoriatic Skin: Relationship with Itch
  134. Podoplanin Expression Correlates with Disease Progression in Mycosis Fungoides
  135. Quality of Life of Parents of Children with Atopic Dermatitis
  136. Severe exacerbation of psoriasis after cessation of methotrexate therapy successfully treated with cyclosporin A
  137. Z życia PTD Stanowisko Polskiego Towarzystwa Dermatologicznego w sprawie wykonywania zabiegów z zakresu medycyny estetycznej oraz diagnostyki i leczenia chorób dermatologicznych przez osoby nieposiadające wykształcenia lekarskiego
  138. Tailoring the Cut-off Values of the Visual Analogue Scale and Numeric Rating Scale in Itch Assessment
  139. Treatment of atopic dermatitis with cyclosporin A: a case report
  140. Trichotillomania Among Young Adults: Prevalence and Comorbidity
  141. Urticarial vasculitis coexisting with primary myelofibrosis – a case report
  142. Treatment of cutaneous lupus erythematosus: current practice variations
  143. <i>Ziziphus mauritiana</i> leaf extract emulsion for skin rejuvenation
  144. Alexithymia in Uraemic Pruritus
  145. Assessment of the severity of atopic dermatitis
  146. Carcinoma en cuirasse as an initial manifestation of inflammatory breast cancer
  147. Chronic Kidney Disease-associated Pruritus in Children
  148. Clinical characteristics of cutaneous lupus erythematosus
  149. Diagnostic Procedures of Itch
  150. Elastosis perforans serpiginosa: a review of the literature and our own experience
  151. Erythema gyratum repens associated with cryptogenic organizing pneumonia
  152. Generalized lichen nitidus: a case report and review of the literature
  153. Itch Assessment with Visual Analogue Scale and Numerical Rating Scale: Determination of Minimal Clinically Important Difference in Chronic Itch
  154. Itch in Psoriasis Management
  155. Lipid Content and Barrier Function Analysis in Uraemic Pruritus
  156. Measurement of Itch Intensity
  157. Natural cold pressed oils as cosmetic products
  158. Psoriasis rupioides with marked nail abnormalities in a HIV-positive patient
  159. Uremic Pruritus Is Not Associated with Endocannabinoid Receptor 1 Gene Polymorphisms
  160. Is uremic pruritus still an important clinical problem in maintenance hemodialysis patients?
  161. Pruritus in psoriasis: An update
  162. European EADV network on assessment of severity and burden of Pruritus (PruNet): first meeting on outcome tools
  163. Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine
  164. Skin disorders in elderly subjects
  165. Systemic antihistamines - a common outside the guidelines therapeutic strategy in hand eczema management
  166. Antiobesity, hypolipidemic, antioxidant and hepatoprotective effects of Achyranthes aspera seed saponins in high cholesterol fed albino rats
  167. Assessment of the sensory threshold in patients with atopic dermatitis and psoriasis
  168. Special papers Diagnostic and therapeutic advances in dermatomyositis
  169. Expression of CXCR4 and CXCL12 and their correlations to the cell proliferation and angiogenesis in mycosis fungoides
  170. IL-31 Is Overexpressed in Lichen Planus but Its Level Does Not Correlate with Pruritus Severity
  171. Disturbed skin barrier in children with chronic kidney disease
  172. Onychophagia is Associated with Impairment of Quality of Life
  173. Onychotillomania in the Course of Depression: A Case Report
  174. Interplay of Itch and Psyche in Psoriasis: An Update
  175. Actinic keratosis – state of art. Statement of experts of Polish Dermatological Society
  176. Apprehension of the disease by patients suffering from psoriasis
  177. Onychophagia and Onychotillomania: Prevalence, Clinical Picture and Comorbidities
  178. Prevalence of Demodex spp. in eyelash follicles in different populations
  179. Treatment of psoriasis vulgaris: guidelines of experts of the Polish Dermatological Society. Part II: moderate to severe psoriasis
  180. Uraemic Pruritus Markedly Affects the Quality of Life and Depressive Symptoms in Haemodialysis Patients with End-stage Renal Disease
  181. Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia
  182. Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Multiple Intravenous, Dose‐Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus
  183. Pruritus intensity assessment: challenge for clinicians
  184. Effects of Narrow Band UVB (311 nm) Irradiation on Epidermal Cells
  185. Cutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)
  186. Altered expression of Bcl-2 , c-Myc , H-Ras , K-Ras , and N-Ras does not influence the course of mycosis fungoides
  187. Itchy Hair – Trichoknesis: A Variant of Trichodynia or a New Entity?
  188. Mediators of Pruritus in Lichen Planus
  189. Pruritus Assessment in Clinical Trials: Consensus Recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials
  190. Verbalizing Extremes of the Visual Analogue Scale for Pruritus: A Consensus Statement
  191. Non-Analgesic Effects of Opioids: Peripheral Opioid Receptors as Promising Targets for Future Anti-Pruritic Therapies
  192. Erratum zu: Erfassung von Pruritus: aktuelle Standards und Implikationen für die Praxis
  193. Erfassung von Pruritus – aktuelle Standards und Implikationen für die Praxis
  194. Relationship between itch and psychological status of patients with atopic dermatitis
  195. Altered microRNA expression in mycosis fungoides
  196. Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus
  197. Patients with Psoriasis Feel Stigmatized
  198. Letter to the Editor Subacute cutaneous lupus erythematosus due to proton pump inhibitor intake: and literature review
  199. Health-Related Quality of Life in Patients with Nail Disorders
  200. Photoprovocation in Cutaneous Lupus Erythematosus: A Multicenter Study Evaluating a Standardized Protocol
  201. The lupus band test in systemic lupus erythematosus patients
  202. Pruritus Differences Between Psoriasis and Lichen Planus
  203. Pruritus in the elderly
  204. Definition of treatment goals for moderate to severe psoriasis: a European consensus
  205. Lipidome of narrow‐band ultraviolet B irradiated keratinocytes shows apoptotic hallmarks
  206. Primary cutaneous peripheral T‐cell non‐Hodgkin lymphoma, not otherwise specified, with cytotoxic features
  207. Enhanced enzymatic activity of Candida species responsible for oral candidiasis in renal transplant recipients
  208. Opioid-induced pruritus: an update
  209. Pruritus is an Important Factor Negatively Influencing the Well-being of Psoriatic Patients
  210. Application of sunscreen preparations: a need to change the regulations
  211. Cannabinoid system in the skin – a possible target for future therapies in dermatology
  212. Periungual lesions in pyoderma gangrenosum
  213. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level
  214. Stigmatisation in onychomycosis patients: a population‐based study
  215. Clinical Aspects of Itch in Adult Atopic Dermatitis Patients
  216. Drug-induced Pruritus: A Review
  217. Is Pruritus in Depression a Rare Phenomenon?
  218. Narrow‐band UVB‐induced Externalization of Selected Nuclear Antigens in Keratinocytes: Implications for Lupus Erythematosus Pathogenesis†
  219. Onychophagia as a Spectrum of Obsessive-compulsive Disorder
  220. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study
  221. Dardia® Lipo Milk improves skin dryness: a corneometric assessment
  222. Surface morphology and mechanical properties of fibroblasts from scleroderma patients
  223. Quality of life in patients with seborrheic dermatitis
  224. Acne Itch: Do Acne Patients Suffer From Itching?
  225. Haemorrhagic Nails in Pemphigus Vulgaris
  226. Vulvar Pruritus and Burning Sensation in Women with Psoriasis
  227. Acne and itch: direct relationship or comorbidity?
  228. Chronic metastatic neuroblastoma
  229. Structural alterations provoked by narrow‐band ultraviolet B in immortalized keratinocytes: assessment by atomic force microscopy
  230. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis‐specific questionnaire
  231. Plasma concentration of selected neuropeptides in patients suffering from psoriasis
  232. Mediators of Pruritus in Psoriasis
  233. PAX3-FKHRANDPAX7-FKHRFUSION GENES IMPACT OUTCOME OF ALVEOLAR RHABDOMYOSARCOMA IN CHILDREN
  234. Plasma Neuropeptides and Perception of Pruritus in Psoriasis
  235. Vascular adhesion protein‐1 (VAP‐1) is overexpressed in psoriatic patients
  236. Factors Influencing Coexistence of Toenail Onychomycosis With Tinea Pedis and Other Dermatomycoses
  237. Drug‐induced subacute cutaneous lupus erythematosus resulting from ticlopidine
  238. Severe Acute Generalized Exanthematous Pustulosis in a Pregnant Woman
  239. Expression of Vascular Adhesion Protein-1 in Atopic Eczema
  240. Keratoacanthoma-like Cutaneous Metastasis of Lung Cancer: a Learning Point
  241. Psoriasiform lupus vulgaris with 30 years duration
  242. Emollients With Endocannabinoids in the Treatment of Uremic Pruritus: Discussion of the Therapeutic Options
  243. Sun Protection in Renal Transplant Recipients: Urgent Need for Education
  244. Pruritus and psoriasis
  245. The role of nuclear morphometry in prediction of prognosis for rhabdomyosarcoma in children
  246. Uraemic xerosis
  247. Delusional Parasitosis Successfully Controlled with Risperidone – Two Case Reports
  248. Histamine, Substance P and Calcitonin Gene-Related Peptide Plasma Concentration and Pruritus in Patients Suffering from Psoriasis
  249. Psychodermatoses in Haemodialysis Patients
  250. Remaining Problems and Controversies in the Management of Childhood Head and Neck Soft Tissue Sarcomas: Retrospective (National) Multicenter Study of the Polish Pediatric Solid Tumors Group
  251. Does Stress Influence Itching in Psoriatic Patients?